We Need to Rethink Our Treatment of Painnews2023-12-24T14:00:21+00:00December 24th, 2023|The New York Times|
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billionnews2023-12-22T17:55:31+00:00December 22nd, 2023|The New York Times|
Fake Ozempic Found in U.S., F.D.A. Warnsnews2023-12-22T16:06:00+00:00December 22nd, 2023|The New York Times|
Possible Ways to Ease Drug Shortagesnews2023-12-19T16:05:37+00:00December 19th, 2023|The New York Times|
Behind the Shortage Keeping Cancer Patients From Chemonews2023-12-19T08:01:01+00:00December 19th, 2023|The New York Times|
What to Know About the Effects of Ketaminenews2023-12-16T16:55:07+00:00December 16th, 2023|The New York Times|
F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editingnews2023-12-09T02:22:13+00:00December 9th, 2023|The New York Times|
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Mostnews2023-12-08T22:46:17+00:00December 8th, 2023|The New York Times|
Why We’re Stuck in a Constant Cycle of Drug Shortagesnews2023-12-06T14:05:41+00:00December 6th, 2023|The New York Times|
¿Un medicamento para que tu perro viva más?news2023-11-30T12:44:11+00:00November 30th, 2023|The New York Times|
